Early detection of liver disease, often a “silent” condition, can be dramatically improved through routine screening at community health clinics, according to a new pilot study from researchers at Brown University. The findings, published in the Rhode Island Medical Journal, suggest a pathway to address disparities in diagnosis and treatment, particularly among populations at higher risk. The study highlights the potential of integrating simple diagnostic tests and brief counseling into existing healthcare visits to identify and address liver problems before they become life-threatening.
Liver disease, encompassing conditions like fatty liver disease, hepatitis, and cirrhosis, often progresses without noticeable symptoms until significant damage has occurred. This delay in diagnosis is a major contributor to the growing number of liver-related deaths, and disproportionately affects individuals with limited access to specialized care. The researchers focused on nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), increasingly common conditions linked to obesity, diabetes, and metabolic syndrome. Without intervention, deaths caused by chronic liver disease are projected to double by 2040, with vulnerable populations bearing the brunt of the increase.
The pilot study, conducted in partnership with Clínica Esperanza, a Rhode Island clinic serving uninsured adults, involved screening 14 patients during their regular check-ups. Researchers reviewed electronic health records to identify individuals with a body mass index (BMI) of 25 or higher and those who scored at-risk on an alcohol use disorder assessment. Those meeting the criteria underwent further evaluation, including a non-invasive liver stiffness test using a FibroScan device, which measures the degree of fibrosis (scarring) in the liver. The results were striking: 21% of participants showed signs of liver stiffness, and 57% were found to have steatosis, or fat accumulation in the liver. Critically, none of these individuals had been previously aware of their condition.
Bridging the Gap in Early Detection
“One of the biggest factors causing disparities in who progresses to the most severe liver disease and then eventually dies waiting on transplant lists is they were not diagnosed early enough and never offered appropriate treatment,” explained Hayley Treloar Padovano, an associate professor at Brown University’s School of Public Health and Warren Alpert Medical School, and lead author of the study. The research team emphasized that early identification allows for lifestyle modifications – changes in diet and alcohol consumption – that can often reverse or slow the progression of liver damage.
Following the diagnostic screening, participants were randomly assigned to receive either brief advice from a healthcare provider or motivational interviewing, a counseling technique designed to help individuals explore their ambivalence about change and strengthen their commitment to healthier behaviors. All participants were connected with resources available at the clinic, including programs focused on substance use reduction and cardiometabolic health. Results from the FibroScan were shared with the patients’ primary care teams to facilitate ongoing monitoring and management.
The Power of Personalized Feedback
The study’s findings suggest that even a brief intervention can have a significant impact. “Although the intervention lasted only 30 days, the qualitative feedback from patients was very strong,” said Mollie Monnig, an associate professor of behavioral and social sciences at Brown University. “Many expressed surprise at the condition and gratitude for feeling empowered to do something about it.” Researchers observed that providing personalized feedback based on the FibroScan results helped patients understand their risk factors and motivated them to adopt healthier habits.
The success of the pilot study hinges on its integration within an existing community healthcare system. Clínica Esperanza’s focus on culturally sensitive care and its commitment to serving uninsured populations were crucial to the study’s reach. The clinic’s established relationships with patients and its ability to provide comprehensive care created a supportive environment for screening and intervention. This approach bypasses many of the traditional barriers to liver disease diagnosis, such as lack of awareness, limited access to specialists, and financial constraints.
The researchers are now seeking funding to conduct a larger, randomized controlled trial to further evaluate the effectiveness of this integrated screening and intervention program. The expanded study will aim to determine the optimal duration and intensity of the intervention, as well as identify the most effective strategies for reaching diverse populations. The project, initially funded by the National Institutes of Health through the Center for Addiction and Disease Risk Exacerbation at Brown’s School of Public Health, represents a promising step towards reducing the burden of liver disease and improving health equity.
The team also included Dr. Kittichai Promrat, a gastroenterologist and hepatologist with Brown University Health’s Center for Inflammatory Bowel and Liver Disease, and Stephanie Goldstein, an associate professor of psychiatry and human behavior (research) at Brown.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It’s essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
The researchers hope their work will encourage other community health clinics to adopt similar screening programs, ultimately leading to earlier diagnosis and improved outcomes for individuals at risk of liver disease. The next step involves securing funding for the larger-scale trial, with results anticipated within the next three to five years. Share this information with your network and join the conversation about proactive liver health.
